0
Communications to the Editor |

Bronchial Arterial Infusion for Lung Cancer FREE TO VIEW

David J. Barnes, MBBS, FCCP
Author and Funding Information

RPAH Medical Centre Newtown, New South Wales, Australia

Correspondence to: David J. Barnes, MBBS, FCCP, Respiratory and Sleep Physician, RPAH Medical Centre, Suite 413, 100 Carillon Ave, Newtown, New South Wales 2042; e-mail: dbarnes@nsw.bigpond.net.au



Chest. 2000;117(5):1525. doi:10.1378/chest.117.5.1525
Text Size: A A A
Published online

To The Editor:

Osaki and colleagues (May 1999)1have recently reported their experience with bronchial arterial infusion (BAI) of chemotherapy in centrally located early stage lung cancer. They report prolonged disease-free survival in six of seven patients treated in this manner, with one patient dying of massive hemoptysis 3 months after BAI. While this is an interesting pilot study, there are a number of questions raised by this report, mainly related to patient selection. Four patients had a single carcinoma in situ lesion (stage 0), while the remaining three patients had a carcinoma in situ lesion in addition to a latter stage carcinoma (T2, T3, or T4). All isolated carcinoma in situ lesions seem to have been diagnosed on sputum cytology alone. It is not clear in the report whether those with isolated in situ lesions were symptomatic or whether the cytology was done as part of a screening program for high-risk individuals. No mention is made of bronchial biopsies, and it is therefore assumed that the diagnosis was made on cytology alone. Most would agree that this pathologic diagnosis is difficult to make on cytology alone and usually requires bronchial biopsy.2

A beneficial effect of BAI on survival cannot be assumed from this pilot study. In the first instance, all invasive carcinomas were managed by appropriate surgical resection. Secondly, the prognosis of carcinoma in situ lesions of the bronchus is generally very good. The finding of carcinoma in situ at the bronchial margin after resection for bronchogenic carcinoma has been shown to have no adverse effect on survival, suggesting an inherently good prognosis for in situ lesions.35 Future studies of BAI would therefore require inclusion of patients other than those with stage 0 disease.

Patients with carcinoma in situ may not require active therapeutic intervention, given the absence of any adverse impact on survival when this pathology is present.

References

Osaki, T, Hanagiri, T, Nakanishi, R, et al (1999) Bronchial arterial infusion is an effective therapeutic modality for centrally located early-stage lung cancer.Chest115,1424-1428. [CrossRef] [PubMed]
 
Tao, LC, Chamberlain, DW, Delarue, NC, et al Cytologic diagnosis of radiographically occult squamous cell carcinoma of the lung.Cancer1982;50,1580-1586. [CrossRef] [PubMed]
 
Law, MR, Hodson, ME, Lennox, SC Implications of histologically reported residual tumour on the bronchial margin after resection for bronchial carcinoma.Thorax1982;37,492-495. [CrossRef] [PubMed]
 
Snijder, RJ, Brutel de la Riviere, A, Elbers, HJ, et al Survival in resected stage 1 lung cancer with residual tumor at the bronchial resection margin.Ann Thorac Surg1998;65,212-216. [CrossRef] [PubMed]
 
Nagamoto, N, Saito, Y, Sato, M, et al Clinicopathological analysis of 19 cases of isolated carcinomain situof the bronchus.Am J Surg Pathol1993;17,1234-1243. [CrossRef] [PubMed]
 

Figures

Tables

References

Osaki, T, Hanagiri, T, Nakanishi, R, et al (1999) Bronchial arterial infusion is an effective therapeutic modality for centrally located early-stage lung cancer.Chest115,1424-1428. [CrossRef] [PubMed]
 
Tao, LC, Chamberlain, DW, Delarue, NC, et al Cytologic diagnosis of radiographically occult squamous cell carcinoma of the lung.Cancer1982;50,1580-1586. [CrossRef] [PubMed]
 
Law, MR, Hodson, ME, Lennox, SC Implications of histologically reported residual tumour on the bronchial margin after resection for bronchial carcinoma.Thorax1982;37,492-495. [CrossRef] [PubMed]
 
Snijder, RJ, Brutel de la Riviere, A, Elbers, HJ, et al Survival in resected stage 1 lung cancer with residual tumor at the bronchial resection margin.Ann Thorac Surg1998;65,212-216. [CrossRef] [PubMed]
 
Nagamoto, N, Saito, Y, Sato, M, et al Clinicopathological analysis of 19 cases of isolated carcinomain situof the bronchus.Am J Surg Pathol1993;17,1234-1243. [CrossRef] [PubMed]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543